Global Decitabine Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 106
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- 10 Mg Dosage Forms

- 15 Mg Dosage Forms

- 25 Mg Dosage Forms

Segment by Application

- Primary MDS

- Secondary MDS

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Johnson & Johnson

- Eli Lilly and Company

- Pharmachemie B.V.

- Otsuka Pharmaceutical

- Sandoz

- Dr Reddy's Laboratories

- Accord Healthcare

- Sun Pharmaceutical

- Cipla

- Lupin

- Shandong Xinshidai Pharmaceutical

- Hangzhou Zhongmei Huadong Pharmaceutical

- ZHENGDA Tianqing Pharmaceutical Group

- Jiangsu Aosaikang Pharmaceutical

- Jiangsu Haosen Pharmaceutical Group

- Lianyungang Jierui Pharmaceutical

- Qilu Pharmaceutical Hainan

- Lianyungang Runzhong Pharmaceutical

Global Decitabine Market Research Report 2022

Table of Contents
1 Decitabine Market Overview
1.1 Product Overview and Scope of Decitabine
1.2 Decitabine Segment by Type
1.2.1 Global Decitabine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 10 Mg Dosage Forms
1.2.3 15 Mg Dosage Forms
1.2.4 25 Mg Dosage Forms
1.3 Decitabine Segment by Application
1.3.1 Global Decitabine Sales Comparison by Application: (2022-2028)
1.3.2 Primary MDS
1.3.3 Secondary MDS
1.4 Global Decitabine Market Size Estimates and Forecasts
1.4.1 Global Decitabine Revenue 2017-2028
1.4.2 Global Decitabine Sales 2017-2028
1.4.3 Decitabine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Decitabine Market Competition by Manufacturers
2.1 Global Decitabine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Decitabine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Decitabine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Decitabine Manufacturing Sites, Area Served, Product Type
2.5 Decitabine Market Competitive Situation and Trends
2.5.1 Decitabine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Decitabine Players Market Share by Revenue
2.5.3 Global Decitabine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Decitabine Retrospective Market Scenario by Region
3.1 Global Decitabine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Decitabine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Decitabine Market Facts & Figures by Country
3.3.1 North America Decitabine Sales by Country
3.3.2 North America Decitabine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Decitabine Market Facts & Figures by Country
3.4.1 Europe Decitabine Sales by Country
3.4.2 Europe Decitabine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Decitabine Market Facts & Figures by Region
3.5.1 Asia Pacific Decitabine Sales by Region
3.5.2 Asia Pacific Decitabine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Decitabine Market Facts & Figures by Country
3.6.1 Latin America Decitabine Sales by Country
3.6.2 Latin America Decitabine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Decitabine Market Facts & Figures by Country
3.7.1 Middle East and Africa Decitabine Sales by Country
3.7.2 Middle East and Africa Decitabine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Decitabine Historic Market Analysis by Type
4.1 Global Decitabine Sales Market Share by Type (2017-2022)
4.2 Global Decitabine Revenue Market Share by Type (2017-2022)
4.3 Global Decitabine Price by Type (2017-2022)
5 Global Decitabine Historic Market Analysis by Application
5.1 Global Decitabine Sales Market Share by Application (2017-2022)
5.2 Global Decitabine Revenue Market Share by Application (2017-2022)
5.3 Global Decitabine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Johnson & Johnson Decitabine Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Eli Lilly and Company
6.2.1 Eli Lilly and Company Corporation Information
6.2.2 Eli Lilly and Company Description and Business Overview
6.2.3 Eli Lilly and Company Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Eli Lilly and Company Decitabine Product Portfolio
6.2.5 Eli Lilly and Company Recent Developments/Updates
6.3 Pharmachemie B.V.
6.3.1 Pharmachemie B.V. Corporation Information
6.3.2 Pharmachemie B.V. Description and Business Overview
6.3.3 Pharmachemie B.V. Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Pharmachemie B.V. Decitabine Product Portfolio
6.3.5 Pharmachemie B.V. Recent Developments/Updates
6.4 Otsuka Pharmaceutical
6.4.1 Otsuka Pharmaceutical Corporation Information
6.4.2 Otsuka Pharmaceutical Description and Business Overview
6.4.3 Otsuka Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Otsuka Pharmaceutical Decitabine Product Portfolio
6.4.5 Otsuka Pharmaceutical Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Corporation Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Sandoz Decitabine Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Dr Reddy's Laboratories
6.6.1 Dr Reddy's Laboratories Corporation Information
6.6.2 Dr Reddy's Laboratories Description and Business Overview
6.6.3 Dr Reddy's Laboratories Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Dr Reddy's Laboratories Decitabine Product Portfolio
6.6.5 Dr Reddy's Laboratories Recent Developments/Updates
6.7 Accord Healthcare
6.6.1 Accord Healthcare Corporation Information
6.6.2 Accord Healthcare Description and Business Overview
6.6.3 Accord Healthcare Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Accord Healthcare Decitabine Product Portfolio
6.7.5 Accord Healthcare Recent Developments/Updates
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Corporation Information
6.8.2 Sun Pharmaceutical Description and Business Overview
6.8.3 Sun Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Sun Pharmaceutical Decitabine Product Portfolio
6.8.5 Sun Pharmaceutical Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Cipla Decitabine Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Lupin
6.10.1 Lupin Corporation Information
6.10.2 Lupin Description and Business Overview
6.10.3 Lupin Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Lupin Decitabine Product Portfolio
6.10.5 Lupin Recent Developments/Updates
6.11 Shandong Xinshidai Pharmaceutical
6.11.1 Shandong Xinshidai Pharmaceutical Corporation Information
6.11.2 Shandong Xinshidai Pharmaceutical Decitabine Description and Business Overview
6.11.3 Shandong Xinshidai Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Shandong Xinshidai Pharmaceutical Decitabine Product Portfolio
6.11.5 Shandong Xinshidai Pharmaceutical Recent Developments/Updates
6.12 Hangzhou Zhongmei Huadong Pharmaceutical
6.12.1 Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information
6.12.2 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Description and Business Overview
6.12.3 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product Portfolio
6.12.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments/Updates
6.13 ZHENGDA Tianqing Pharmaceutical Group
6.13.1 ZHENGDA Tianqing Pharmaceutical Group Corporation Information
6.13.2 ZHENGDA Tianqing Pharmaceutical Group Decitabine Description and Business Overview
6.13.3 ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.13.4 ZHENGDA Tianqing Pharmaceutical Group Decitabine Product Portfolio
6.13.5 ZHENGDA Tianqing Pharmaceutical Group Recent Developments/Updates
6.14 Jiangsu Aosaikang Pharmaceutical
6.14.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
6.14.2 Jiangsu Aosaikang Pharmaceutical Decitabine Description and Business Overview
6.14.3 Jiangsu Aosaikang Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Jiangsu Aosaikang Pharmaceutical Decitabine Product Portfolio
6.14.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
6.15 Jiangsu Haosen Pharmaceutical Group
6.15.1 Jiangsu Haosen Pharmaceutical Group Corporation Information
6.15.2 Jiangsu Haosen Pharmaceutical Group Decitabine Description and Business Overview
6.15.3 Jiangsu Haosen Pharmaceutical Group Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Jiangsu Haosen Pharmaceutical Group Decitabine Product Portfolio
6.15.5 Jiangsu Haosen Pharmaceutical Group Recent Developments/Updates
6.16 Lianyungang Jierui Pharmaceutical
6.16.1 Lianyungang Jierui Pharmaceutical Corporation Information
6.16.2 Lianyungang Jierui Pharmaceutical Decitabine Description and Business Overview
6.16.3 Lianyungang Jierui Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Lianyungang Jierui Pharmaceutical Decitabine Product Portfolio
6.16.5 Lianyungang Jierui Pharmaceutical Recent Developments/Updates
6.17 Qilu Pharmaceutical Hainan
6.17.1 Qilu Pharmaceutical Hainan Corporation Information
6.17.2 Qilu Pharmaceutical Hainan Decitabine Description and Business Overview
6.17.3 Qilu Pharmaceutical Hainan Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Qilu Pharmaceutical Hainan Decitabine Product Portfolio
6.17.5 Qilu Pharmaceutical Hainan Recent Developments/Updates
6.18 Lianyungang Runzhong Pharmaceutical
6.18.1 Lianyungang Runzhong Pharmaceutical Corporation Information
6.18.2 Lianyungang Runzhong Pharmaceutical Decitabine Description and Business Overview
6.18.3 Lianyungang Runzhong Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Lianyungang Runzhong Pharmaceutical Decitabine Product Portfolio
6.18.5 Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
7 Decitabine Manufacturing Cost Analysis
7.1 Decitabine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Decitabine
7.4 Decitabine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Decitabine Distributors List
8.3 Decitabine Customers
9 Decitabine Market Dynamics
9.1 Decitabine Industry Trends
9.2 Decitabine Market Drivers
9.3 Decitabine Market Challenges
9.4 Decitabine Market Restraints
10 Global Market Forecast
10.1 Decitabine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Decitabine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Decitabine by Type (2023-2028)
10.2 Decitabine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Decitabine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Decitabine by Application (2023-2028)
10.3 Decitabine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Decitabine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Decitabine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Decitabine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Decitabine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Decitabine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Decitabine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Decitabine Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Decitabine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Decitabine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Decitabine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Decitabine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Decitabine Manufacturing Sites and Area Served
Table 11. Manufacturers Decitabine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Decitabine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Decitabine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Decitabine Sales by Region (2017-2022) & (K Units)
Table 16. Global Decitabine Sales Market Share by Region (2017-2022)
Table 17. Global Decitabine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Decitabine Revenue Market Share by Region (2017-2022)
Table 19. North America Decitabine Sales by Country (2017-2022) & (K Units)
Table 20. North America Decitabine Sales Market Share by Country (2017-2022)
Table 21. North America Decitabine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Decitabine Revenue Market Share by Country (2017-2022)
Table 23. Europe Decitabine Sales by Country (2017-2022) & (K Units)
Table 24. Europe Decitabine Sales Market Share by Country (2017-2022)
Table 25. Europe Decitabine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Decitabine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Decitabine Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Decitabine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Decitabine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Decitabine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Decitabine Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Decitabine Sales Market Share by Country (2017-2022)
Table 33. Latin America Decitabine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Decitabine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Decitabine Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Decitabine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Decitabine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Decitabine Revenue Market Share by Country (2017-2022)
Table 39. Global Decitabine Sales by Type (2017-2022) & (K Units)
Table 40. Global Decitabine Sales Market Share by Type (2017-2022)
Table 41. Global Decitabine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Decitabine Revenue Share by Type (2017-2022)
Table 43. Global Decitabine Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Decitabine Sales (K Units) by Application (2017-2022)
Table 45. Global Decitabine Sales Market Share by Application (2017-2022)
Table 46. Global Decitabine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Decitabine Revenue Share by Application (2017-2022)
Table 48. Global Decitabine Price by Application (2017-2022) & (US$/Unit)
Table 49. Johnson & Johnson Corporation Information
Table 50. Johnson & Johnson Description and Business Overview
Table 51. Johnson & Johnson Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Johnson & Johnson Decitabine Product
Table 53. Johnson & Johnson Recent Developments/Updates
Table 54. Eli Lilly and Company Corporation Information
Table 55. Eli Lilly and Company Description and Business Overview
Table 56. Eli Lilly and Company Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Eli Lilly and Company Decitabine Product
Table 58. Eli Lilly and Company Recent Developments/Updates
Table 59. Pharmachemie B.V. Corporation Information
Table 60. Pharmachemie B.V. Description and Business Overview
Table 61. Pharmachemie B.V. Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Pharmachemie B.V. Decitabine Product
Table 63. Pharmachemie B.V. Recent Developments/Updates
Table 64. Otsuka Pharmaceutical Corporation Information
Table 65. Otsuka Pharmaceutical Description and Business Overview
Table 66. Otsuka Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Otsuka Pharmaceutical Decitabine Product
Table 68. Otsuka Pharmaceutical Recent Developments/Updates
Table 69. Sandoz Corporation Information
Table 70. Sandoz Description and Business Overview
Table 71. Sandoz Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Sandoz Decitabine Product
Table 73. Sandoz Recent Developments/Updates
Table 74. Dr Reddy's Laboratories Corporation Information
Table 75. Dr Reddy's Laboratories Description and Business Overview
Table 76. Dr Reddy's Laboratories Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Dr Reddy's Laboratories Decitabine Product
Table 78. Dr Reddy's Laboratories Recent Developments/Updates
Table 79. Accord Healthcare Corporation Information
Table 80. Accord Healthcare Description and Business Overview
Table 81. Accord Healthcare Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Accord Healthcare Decitabine Product
Table 83. Accord Healthcare Recent Developments/Updates
Table 84. Sun Pharmaceutical Corporation Information
Table 85. Sun Pharmaceutical Description and Business Overview
Table 86. Sun Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Sun Pharmaceutical Decitabine Product
Table 88. Sun Pharmaceutical Recent Developments/Updates
Table 89. Cipla Corporation Information
Table 90. Cipla Description and Business Overview
Table 91. Cipla Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Cipla Decitabine Product
Table 93. Cipla Recent Developments/Updates
Table 94. Lupin Corporation Information
Table 95. Lupin Description and Business Overview
Table 96. Lupin Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Lupin Decitabine Product
Table 98. Lupin Recent Developments/Updates
Table 99. Shandong Xinshidai Pharmaceutical Corporation Information
Table 100. Shandong Xinshidai Pharmaceutical Description and Business Overview
Table 101. Shandong Xinshidai Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Shandong Xinshidai Pharmaceutical Decitabine Product
Table 103. Shandong Xinshidai Pharmaceutical Recent Developments/Updates
Table 104. Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information
Table 105. Hangzhou Zhongmei Huadong Pharmaceutical Description and Business Overview
Table 106. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product
Table 108. Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments/Updates
Table 109. ZHENGDA Tianqing Pharmaceutical Group Corporation Information
Table 110. ZHENGDA Tianqing Pharmaceutical Group Description and Business Overview
Table 111. ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. ZHENGDA Tianqing Pharmaceutical Group Decitabine Product
Table 113. ZHENGDA Tianqing Pharmaceutical Group Recent Developments/Updates
Table 114. Jiangsu Aosaikang Pharmaceutical Corporation Information
Table 115. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 116. Jiangsu Aosaikang Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Jiangsu Aosaikang Pharmaceutical Decitabine Product
Table 118. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
Table 119. Jiangsu Haosen Pharmaceutical Group Corporation Information
Table 120. Jiangsu Haosen Pharmaceutical Group Description and Business Overview
Table 121. Jiangsu Haosen Pharmaceutical Group Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Jiangsu Haosen Pharmaceutical Group Decitabine Product
Table 123. Jiangsu Haosen Pharmaceutical Group Recent Developments/Updates
Table 124. Lianyungang Jierui Pharmaceutical Corporation Information
Table 125. Lianyungang Jierui Pharmaceutical Description and Business Overview
Table 126. Lianyungang Jierui Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Lianyungang Jierui Pharmaceutical Decitabine Product
Table 128. Lianyungang Jierui Pharmaceutical Recent Developments/Updates
Table 129. Qilu Pharmaceutical Hainan Corporation Information
Table 130. Qilu Pharmaceutical Hainan Description and Business Overview
Table 131. Qilu Pharmaceutical Hainan Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Qilu Pharmaceutical Hainan Decitabine Product
Table 133. Qilu Pharmaceutical Hainan Recent Developments/Updates
Table 134. Lianyungang Runzhong Pharmaceutical Corporation Information
Table 135. Lianyungang Runzhong Pharmaceutical Description and Business Overview
Table 136. Lianyungang Runzhong Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Lianyungang Runzhong Pharmaceutical Decitabine Product
Table 138. Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
Table 139. Production Base and Market Concentration Rate of Raw Material
Table 140. Key Suppliers of Raw Materials
Table 141. Decitabine Distributors List
Table 142. Decitabine Customers List
Table 143. Decitabine Market Trends
Table 144. Decitabine Market Drivers
Table 145. Decitabine Market Challenges
Table 146. Decitabine Market Restraints
Table 147. Global Decitabine Sales Forecast by Type (2023-2028) & (K Units)
Table 148. Global Decitabine Sales Market Share Forecast by Type (2023-2028)
Table 149. Global Decitabine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 150. Global Decitabine Revenue Market Share Forecast by Type (2023-2028)
Table 151. Global Decitabine Sales Forecast by Application (2023-2028) & (K Units)
Table 152. Global Decitabine Sales Market Share Forecast by Application (2023-2028)
Table 153. Global Decitabine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 154. Global Decitabine Revenue Market Share Forecast by Application (2023-2028)
Table 155. Global Decitabine Sales Forecast by Region (2023-2028) & (K Units)
Table 156. Global Decitabine Sales Market Share Forecast by Region (2023-2028)
Table 157. Global Decitabine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 158. Global Decitabine Revenue Market Share Forecast by Region (2023-2028)
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Decitabine
Figure 2. Global Decitabine Market Share by Type in 2021 & 2028
Figure 3. 10 Mg Dosage Forms Product Picture
Figure 4. 15 Mg Dosage Forms Product Picture
Figure 5. 25 Mg Dosage Forms Product Picture
Figure 6. Global Decitabine Market Share by Application in 2021 & 2028
Figure 7. Primary MDS
Figure 8. Secondary MDS
Figure 9. Global Decitabine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Decitabine Market Size (2017-2028) & (US$ Million)
Figure 11. Global Decitabine Sales (2017-2028) & (K Units)
Figure 12. Decitabine Sales Share by Manufacturers in 2021
Figure 13. Global Decitabine Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Decitabine Players: Market Share by Revenue in 2021
Figure 15. Decitabine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Decitabine Sales Market Share by Region (2017-2022)
Figure 17. Global Decitabine Sales Market Share by Region in 2021
Figure 18. Global Decitabine Revenue Market Share by Region (2017-2022)
Figure 19. Global Decitabine Revenue Market Share by Region in 2021
Figure 20. U.S. Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Taiwan Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Philippines Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Vietnam Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Decitabine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Decitabine by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Decitabine
Figure 46. Manufacturing Process Analysis of Decitabine
Figure 47. Decitabine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
  • Global Kyphosis Treatment Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 91
    Kyphosis Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Kyphosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Medications - Surgery - Bracing Segment by Application......
  • Global Acquired Immunodeficiency Syndrome Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 94
    Acquired Immunodeficiency Syndrome market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Acquired Immunodeficiency Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Nucleoside Reverse Transcriptase Inhibitors (NRTIs)......
  • Global Ocular Pain Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 87
    Ocular Pain market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Ocular Pain market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Antibacterial Medications - Antiviral Medications - Steroids Segment by......
  • Global Vernal Keratoconjunctivitis Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 83
    Vernal Keratoconjunctivitis market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Vernal Keratoconjunctivitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Topical - Oral Segment by Application -......
  • Global Anaplastic Lymphoma Kinase ALK Inhibitor Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - First Generation ALK Inhibitor - Second Generation ALK Inhibitor - Third Generation ALK Inhibitor ......
  • Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 89
    Adeno-Associated Virus (AAV) Vector-Based Gene Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Single-strande......
  • Global Invasive Fungal Infection Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 97
    Invasive Fungal Infection market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Invasive Fungal Infection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Diagnosis - Treatment Segment by Application......
  • Global Essential Oil and Aromatherapy Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 89
    Essential Oil and Aromatherapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Essential Oil and Aromatherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Essential Oils - Blended Oils - Carrier Oils......
  • Global Tennis Elbow Treatment Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 90
    Tennis Elbow Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Tennis Elbow Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Surgical Therapies - Extracorporeal Shock Wave Therapy - Medicat......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs